Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: Potential Red Flag for Future Multiple System Atrophy
Pure autonomic failure is challenging as it can be the presenting feature of a central nervous system syncleinopathy such as Parkinson’s disease (PD) or multiple system atrophy (MSA). Because the prognosis of MSA and PD is so different, predictive features for a possible conversion can be extremely...
Main Authors: | Francesca Baschieri, Giovanna Calandra-Buonaura, Annagrazia Cecere, Giorgio Barletta, Manuela Contin, Piero Parchi, Pietro Cortelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00225/full |
Similar Items
-
Possible multiple system atrophy with predominant parkinsonism in a patient with chronic schizophrenia: a case report
by: Hiroshi Komatsu, et al.
Published: (2018-05-01) -
Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
by: Hiroshi Wakabayashi, et al.
Published: (2020-09-01) -
Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease.
by: Mauro Ursino, et al.
Published: (2020-01-01) -
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
by: Thomas Blom, et al.
Published: (2021-08-01) -
The significance of metaiodobenzylguanidine scintigraphy in the treatment of high risk neuroblastomas
by: Nikolić Katarina, et al.
Published: (2020-01-01)